NCT02894372

Faringomoss Effectiveness in Inhibiting Acute Throat Pain and Discomfort

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 96 (actual)
• Sponsor: Lithuanian University of Health Sciences · Academic / Other
• Sex: All
• Age: 6 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study was to assess the effectiveness of Faringomoss in reducing the throat discomfort and pain in patients with acute throat diseases and postoperative patients after throat surgeries.

Detailed description

Study objectives were: 1. To asses the symptoms of throat pain and discomfort after pharyngeal surgery in early postoperative period. 2. To evaluate those symptoms also in outpatient subjects with acute throat pain and discomfort. 3. To compare the data of different groups of patients who had received the topical throat spray with the placebo group. 4. To estimate the gender, age and surgery impact on the results. 5. To record the side effects of the topical sprays. Patients were selected from Lithuanian University of Health Sciences Ear-Nose-Throat department and Vita Longa Clinic outpatients. In random order research participants got a topical spray to use for 7 days after the surgery or from the start of acute throat infection. Neither the patient nor the investigator did not know if it was the medical device (Faringomoss) or the placebo. All the participants got a standard care and treatment with non-steroidal anti-inflammatory drugs. The intent was to investigate about 70 - 80 subjects. All the research subjects were tested using objective methods. The confidentiality of the participation was guaranteed. The names were anonymous. The results were summarized. Faringomoss is a topical spray, approved as a medical device. It is not harmful because it is made of vegetable oils.

Conditions

• Spraying Behavior
• Mouth Diseases
• Throat Diseases
• Throat Pain

Interventions

Type	Name	Description
DEVICE	Oral spray 1	Research participants got topical oral spray immediately after surgery (hospital patients) and from the first doctor visit with pharyngeal disease (clinic outpatients).
DEVICE	Oral spray 2	Research participants got topical oral spray immediately after surgery (hospital patients) and from the first doctor visit with pharyngeal disease (clinic outpatients).

Timeline

• Start date: 2015-01-01
• Primary completion: 2016-11-01
• Completion: 2016-12-30
• First posted: 2016-09-09
• Last updated: 2017-03-13

Locations

1 site across 1 country: Lithuania